TLX News: Telix APAC Report: Regulatory Progress for Prostate and Kidney Cancer Imaging - 2nd Aug 2022, 8:54am

[annb0t]

MELBOURNE, Australia, Aug. 2, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports on regulatory progress for the Company's core prostate and kidney cancer imaging programs in the Asia Pacific (APAC) Operating Region, including progress in the major market of China with its strategic partner Grand Pharmaceutical Group Limited (Grand Pharma). (PRNewsfoto/Telix Pharmaceuticals Limited)

TLX591-CDx (Illuccix®) for prostate cancer imaging

China: An Inve...

>>> Read more: Telix APAC Report: Regulatory Progress for Prostate and Kidney Cancer Imaging